Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SHS NEW
-
Total 13F shares
-
1,783,229
-
Share change
-
-156,246
-
Total reported value
-
$29,172,000
-
Price per share
-
$16.36
-
Number of holders
-
19
-
Value change
-
-$2,661,400
-
Number of buys
-
13
-
Number of sells
-
9
Institutional Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q4 2021
As of 31 Dec 2021,
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,783,229 shares.
The largest 10 holders included
INVESTMENT MANAGEMENT OF VIRGINIA LLC, Roumell Asset Management, LLC, VILLERE ST DENIS J & CO LLC, ARK Investment Management LLC, BROWN ADVISORY INC, BENJAMIN F. EDWARDS & COMPANY, INC., Zurcher Kantonalbank (Zurich Cantonalbank), Weil Company, Inc., Kingsview Wealth Management, LLC, and LPL Financial LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.